{
  "paper_metadata": {
    "pmid": "30606148",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6491_6494delAGTT",
      "protein_notation": "p.Gln2164Argfs*3",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "50-59 years, female",
        "phenotype": "high grade serous carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 50,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "high grade serous carcinoma",
          "evidence_sentence": "Patients with high grade serous carcinoma were found to carry a P or LP variant in 24.5% of cases."
        }
      ],
      "functional_data": {
        "summary": "The variant leads to a frameshift and is classified as pathogenic.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Table 2, Row 38",
      "additional_notes": "This variant is associated with a high risk of ovarian cancer.",
      "key_quotes": [
        "Patients with high grade serous carcinoma were found to carry a P or LP variant in 24.5% of cases."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3680_3681delTG",
      "protein_notation": "p.Leu1227Glnfs*5",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "60-69 years, female",
        "phenotype": "high grade serous carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 60,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "high grade serous carcinoma",
          "evidence_sentence": "Patients with high grade serous carcinoma were found to carry a P or LP variant in 24.5% of cases."
        }
      ],
      "functional_data": {
        "summary": "The variant leads to a frameshift and is classified as pathogenic.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Table 2, Row 39",
      "additional_notes": "This variant is associated with a high risk of ovarian cancer.",
      "key_quotes": [
        "Patients with high grade serous carcinoma were found to carry a P or LP variant in 24.5% of cases."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.738delT",
      "protein_notation": "p.Phe246Leufs*5",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "40-49 years, female",
        "phenotype": "high grade serous carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 40,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "high grade serous carcinoma",
          "evidence_sentence": "Patients with high grade serous carcinoma were found to carry a P or LP variant in 24.5% of cases."
        }
      ],
      "functional_data": {
        "summary": "The variant leads to a frameshift and is classified as likely pathogenic.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Table 2, Row 44",
      "additional_notes": "This variant is associated with a high risk of ovarian cancer.",
      "key_quotes": [
        "Patients with high grade serous carcinoma were found to carry a P or LP variant in 24.5% of cases."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Description of BRCA1 and BRCA2 variants and clinical and pathological characteristics",
      "variants_extracted": 3
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted with detailed penetrance data."
  }
}